Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
NCT01782443
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Carcinoid Tumor
Interventions
DRUG:
Ziv-aflibercept
Sponsor
Dana-Farber Cancer Institute